Winthrop Advisory Group’s Idexx Laboratories IDXX Stock Holding History

Winthrop Advisory Group’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-338	Closed	-$223K	–	144
2021 Q4	$223K	Sell	338 -12	-3%	-$7.53K	0.04%	129
2021 Q3	$218K	Sell	350 -27	-7%	-$18.1K	0.05%	126
2021 Q2	$238K	Sell	377 -59	-14%	-$32.6K	0.05%	116
2021 Q1	$213K	Sell	436 -16	-4%	-$8.02K	0.05%	126
2020 Q4	$226K	Buy	+452	New	+$202K	0.06%	115
2018 Q4	–	Sell	-850	Closed	-$212K	–	94
2018 Q3	$212K	Sell	850 -94	-10%	-$22.8K	0.12%	81
2018 Q2	$206K	Buy	+944	New	+$195K	0.14%	75

Other funds holding IDXX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Winthrop Advisory Group's IDXX Position: Q1 2022 in Review

Winthrop Advisory Group sold out of Idexx Laboratories (IDXX) in Q1 2022, closing a stake of 338 shares — an estimated $223K sold.

Winthrop Advisory Group first reported a position in IDXX in Q2 2018 and held it in 7 quarters. The position peaked at $238K in Q2 2021. 1,032 funds tracked by Wall St. Rank hold IDXX as of Q1 2022.

Winthrop Advisory Group reported no remaining Idexx Laboratories position as of Q1 2022 after selling out during the quarter.
Winthrop Advisory Group sold 338 Idexx Laboratories shares in Q1 2022, an estimated $223K.
Winthrop Advisory Group first reported a position in Idexx Laboratories in Q2 2018 and held it in 7 quarters.
Winthrop Advisory Group's Idexx Laboratories position peaked at $238K in Q2 2021.
1,032 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2022.

Based on Winthrop Advisory Group's 13F filing for Q1 2022, filed 13 Apr 2022.